학술논문
전자자료 공정이용 안내
우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.
공정이용 지침
- 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
- 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
- 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
- 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
- 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
- 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
- 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
- 상업적·영리적 목적으로 자료를 전송·복제·활용
- ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
- EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
- 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
- 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
- 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문'
에서 검색결과 6건 | 목록
1~20
Academic Journal
Stok, Jorn E; Oosenbrug, Timo; ter Haar, Laurens R; Gravekamp, Dennis; Bromley, Christian P; Zelenay, Santiago; Reis e Sousa, Caetano; van der Veen, Annemarthe G
Academic Journal
Pelly, Victoria S; Moeini, Agrin; Roelofsen, Lisanne M; Bonavita, Eduardo; Bell, Charlotte R; Hutton, Colin; Blanco-Gomez, Adrian; Banyard, Antonia; Bromley, Christian P; Flanagan, Eimear; Chiang, Shih-Chieh; Jorgensen, Claus; Schumacher, Ton N; Thommen, Daniela S; Zelenay, Santiago
Pelly, V, Moeini Mortazavi, A, Roelofsen, L M, Bonavita, E, Bell, C, Hutton, C, Blanco Gomez, A, Banyard, A, Bromley, C, Flanagan, E, Chiang, S-C, Jorgensen, C, Schumacher, T N, Thommen, D S & Zelenay, S 2021, 'Anti-inflammatory drugs remodel the tumor immune environment to enhance immune checkpoint blockade efficacy', Cancer discovery, vol. 11, no. 10, pp. 2602–2619. https://doi.org/10.1158/2159-8290.CD-20-1815
Cancer Discovery
Cancer Discovery
Academic Journal
Bell CR; Cancer Inflammation and Immunity Group, Cancer Research UK Manchester Institute, The University of Manchester, Alderley Park, Manchester, UK.; Pelly VS; Cancer Inflammation and Immunity Group, Cancer Research UK Manchester Institute, The University of Manchester, Alderley Park, Manchester, UK.; Moeini A; Cancer Inflammation and Immunity Group, Cancer Research UK Manchester Institute, The University of Manchester, Alderley Park, Manchester, UK.; Chiang SC; Cancer Inflammation and Immunity Group, Cancer Research UK Manchester Institute, The University of Manchester, Alderley Park, Manchester, UK.; Flanagan E; Cancer Inflammation and Immunity Group, Cancer Research UK Manchester Institute, The University of Manchester, Alderley Park, Manchester, UK.; Bromley CP; Cancer Inflammation and Immunity Group, Cancer Research UK Manchester Institute, The University of Manchester, Alderley Park, Manchester, UK.; Clark C; Molecular Biology Core Facility, Cancer Research UK Manchester Institute, The University of Manchester, Alderley Park, Manchester, UK.; Earnshaw CH; Cancer Inflammation and Immunity Group, Cancer Research UK Manchester Institute, The University of Manchester, Alderley Park, Manchester, UK.; Koufaki MA; Cancer Inflammation and Immunity Group, Cancer Research UK Manchester Institute, The University of Manchester, Alderley Park, Manchester, UK.; Bonavita E; Cancer Inflammation and Immunity Group, Cancer Research UK Manchester Institute, The University of Manchester, Alderley Park, Manchester, UK.; Zelenay S; Cancer Inflammation and Immunity Group, Cancer Research UK Manchester Institute, The University of Manchester, Alderley Park, Manchester, UK. Santiago.Zelenay@cruk.manchester.ac.uk.; The Lydia Becker Institute of Immunology and Inflammation, The University of Manchester, Manchester, UK. Santiago.Zelenay@cruk.manchester.ac.uk.
Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE
Academic Journal
Nalio Ramos R; PSL University, Institut Curie Research Center, INSERM U932 & SiRIC, Translational Immunotherapy Team, 75005 Paris, France.; Missolo-Koussou Y; PSL University, Institut Curie Research Center, INSERM U932 & SiRIC, Translational Immunotherapy Team, 75005 Paris, France.; Gerber-Ferder Y; PSL University, Institut Curie Research Center, INSERM U932 & SiRIC, Translational Immunotherapy Team, 75005 Paris, France.; Bromley CP; Cancer Inflammation and Immunity Group, Cancer Research UK Manchester Institute, The University of Manchester, Alderley Park, Manchester, UK.; Bugatti M; Department of Pathology, University of Brescia, Brescia 25123, Italy.; Núñez NG; PSL University, Institut Curie Research Center, INSERM U932 & SiRIC, Translational Immunotherapy Team, 75005 Paris, France.; Tosello Boari J; PSL University, Institut Curie Research Center, INSERM U932 & SiRIC, Translational Immunotherapy Team, 75005 Paris, France.; Richer W; PSL University, Institut Curie Research Center, INSERM U932 & SiRIC, Translational Immunotherapy Team, 75005 Paris, France.; Menger L; PSL University, Institut Curie Research Center, INSERM U932, 75005 Paris, France.; Denizeau J; PSL University, Institut Curie Research Center, INSERM U932 & SiRIC, Translational Immunotherapy Team, 75005 Paris, France.; Sedlik C; PSL University, Institut Curie Research Center, INSERM U932 & SiRIC, Translational Immunotherapy Team, 75005 Paris, France.; Caudana P; PSL University, Institut Curie Research Center, INSERM U932 & SiRIC, Translational Immunotherapy Team, 75005 Paris, France.; Kotsias F; PSL University, Institut Curie Research Center, INSERM U932 & SiRIC, Translational Immunotherapy Team, 75005 Paris, France.; Niborski LL; PSL University, Institut Curie Research Center, INSERM U932 & SiRIC, Translational Immunotherapy Team, 75005 Paris, France.; Viel S; PSL University, Institut Curie Research Center, INSERM U932 & SiRIC, Translational Immunotherapy Team, 75005 Paris, France.; Bohec M; PSL University, Institut Curie Research Center, Institut Curie Genomics of Excellence Platform, 75005 Paris, France.; Lameiras S; PSL University, Institut Curie Research Center, Institut Curie Genomics of Excellence Platform, 75005 Paris, France.; Baulande S; PSL University, Institut Curie Research Center, Institut Curie Genomics of Excellence Platform, 75005 Paris, France.; Lesage L; PSL University, Institut Curie Hospital, Department of Pathology, 75005 Paris, France.; Nicolas A; PSL University, Institut Curie Hospital, Department of Pathology, 75005 Paris, France.; Meseure D; PSL University, Institut Curie Hospital, Department of Pathology, 75005 Paris, France.; Vincent-Salomon A; PSL University, Institut Curie Hospital, Department of Pathology, 75005 Paris, France.; Reyal F; PSL University, Institut Curie Hospital, Department of Surgery, 75005 Paris, France.; Dutertre CA; Université Paris-Saclay, Institut Gustave Roussy, INSERM U1015, Villejuif, France.; Ginhoux F; Université Paris-Saclay, Institut Gustave Roussy, INSERM U1015, Villejuif, France; Singapore Immunology Network, Agency for Science, Technology and Research, Singapore 138648, Singapore.; Vimeux L; University of Paris, Institut Cochin, INSERM U1016, CNRS UMR 8104, 75014 Paris, France.; Donnadieu E; University of Paris, Institut Cochin, INSERM U1016, CNRS UMR 8104, 75014 Paris, France.; Buttard B; INSERM, Sorbonne Université, Université de Paris, Centre de Recherche des Cordeliers, Laboratory of Integrative Cancer Immunology, Paris, France.; Galon J; INSERM, Sorbonne Université, Université de Paris, Centre de Recherche des Cordeliers, Laboratory of Integrative Cancer Immunology, Paris, France.; Zelenay S; Cancer Inflammation and Immunity Group, Cancer Research UK Manchester Institute, The University of Manchester, Alderley Park, Manchester, UK.; Vermi W; PSL University, Institut Curie Research Center, INSERM U932, 75005 Paris, France; Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110, USA.; Guermonprez P; Université de Paris, Centre for Inflammation Research, CNRS ERL8252, INSERM1149, Paris, France.; Piaggio E; PSL University, Institut Curie Research Center, INSERM U932 & SiRIC, Translational Immunotherapy Team, 75005 Paris, France.; Helft J; PSL University, Institut Curie Research Center, INSERM U932 & SiRIC, Translational Immunotherapy Team, 75005 Paris, France. Electronic address: julie.helft@inserm.fr.
Publisher: Cell Press Country of Publication: United States NLM ID: 0413066 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-4172 (Electronic) Linking ISSN: 00928674 NLM ISO Abbreviation: Cell Subsets: MEDLINE
Academic Journal
Cueto FJ; Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), Madrid, Spain.; Del Fresno C; Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), Madrid, Spain.; Hospital la Paz Institute for Health Research (IdiPAZ), Madrid, Spain.; Brandi P; Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), Madrid, Spain.; Combes AJ; Department of Pathology, University of California, San Francisco, California, USA.; ImmunoX Initiative, University of California, San Francisco, California, USA.; UCSF CoLabs, University of California, San Francisco, California, USA.; Hernández-García E; Department of Immunology, Ophthalmology and ENT, School of Medicine, Universidad Complutense de Madrid, Madrid, Spain.; Sánchez-Paulete AR; Division of Immunology and Immunotherapy, Center for Applied Medical Research, University of Navarra, Pamplona, Spain.; Enamorado M; Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), Madrid, Spain.; Metaorganism Immunity Section, Laboratory of Host Immunity and Microbiome, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.; Bromley CP; Cancer Inflammation and Immunity Group, CRUK Manchester Institute, The University of Manchester, Manchester, UK.; Gomez MJ; Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), Madrid, Spain.; Conde-Garrosa R; Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), Madrid, Spain.; Mañes S; Department of Immunology and Oncology, Centro Nacional de Biotecnología/CSIC, Darwin, Madrid, Spain.; Zelenay S; Cancer Inflammation and Immunity Group, CRUK Manchester Institute, The University of Manchester, Manchester, UK.; Melero I; Division of Immunology and Immunotherapy, Center for Applied Medical Research, University of Navarra, Pamplona, Spain.; Instituto de Investigación Sanitaria de Navarra, Pamplona, Spain.; University Clinic, University of Navarra, Pamplona, Spain.; Centro de Investigación Biomédica en Red Cáncer (CIBERONC), Madrid, Spain.; Iborra S; Department of Immunology, Ophthalmology and ENT, School of Medicine, Universidad Complutense de Madrid, Madrid, Spain.; Krummel MF; Department of Pathology, University of California, San Francisco, California, USA.; Sancho D; Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), Madrid, Spain dsancho@cnic.es.
Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Print Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE
Academic Journal
Bonavita E; Cancer Research UK Manchester Institute, The University of Manchester, Alderley Park, UK.; Bromley CP; Cancer Research UK Manchester Institute, The University of Manchester, Alderley Park, UK.; Jonsson G; Department of Life Sciences, Imperial College London, London, UK.; Pelly VS; Cancer Research UK Manchester Institute, The University of Manchester, Alderley Park, UK.; Sahoo S; Cancer Research UK Manchester Institute, The University of Manchester, Alderley Park, UK.; Walwyn-Brown K; Manchester Collaborative Centre for Inflammation Research, The Lydia Becker Institute of Immunology and Inflammation, The University of Manchester, Manchester, UK.; Mensurado S; Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal.; Moeini A; Cancer Research UK Manchester Institute, The University of Manchester, Alderley Park, UK.; Flanagan E; Cancer Research UK Manchester Institute, The University of Manchester, Alderley Park, UK.; Bell CR; Cancer Research UK Manchester Institute, The University of Manchester, Alderley Park, UK.; Chiang SC; Cancer Research UK Manchester Institute, The University of Manchester, Alderley Park, UK.; Chikkanna-Gowda CP; Cancer Research UK Manchester Institute, The University of Manchester, Alderley Park, UK.; Rogers N; The Francis Crick Institute, London, UK.; Silva-Santos B; Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal.; Jaillon S; Humanitas University, Department of Biomedical Sciences, Humanitas Clinical and Research Center, IRCCS, Milan, Italy.; Mantovani A; Humanitas University, Department of Biomedical Sciences, Humanitas Clinical and Research Center, IRCCS, Milan, Italy.; Reis e Sousa C; The Francis Crick Institute, London, UK.; Guerra N; Department of Life Sciences, Imperial College London, London, UK.; Davis DM; Manchester Collaborative Centre for Inflammation Research, The Lydia Becker Institute of Immunology and Inflammation, The University of Manchester, Manchester, UK.; Zelenay S; Cancer Research UK Manchester Institute, The University of Manchester, Alderley Park, UK. Electronic address: santiago.zelenay@cruk.manchester.ac.uk.
Publisher: Cell Press Country of Publication: United States NLM ID: 9432918 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-4180 (Electronic) Linking ISSN: 10747613 NLM ISO Abbreviation: Immunity Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[AR] Bromley, Christian P
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어